Ann: AGM CEO and Managing Director's Address to Shareholders, page-45

My opinion, which is basically worthless and just an opinion, is that the Aus studies will remind the current holders that the tech actually does in fact work and perhaps create a small revolution to accumulate a nice parcel while the stock is at bargain basement levels, which will rocket us up about 4-6 cents. I wholeheartedly agree with your view that everyone is watching the US trials and as soon as there are any indications that point to FDA approval then this thing goes off like a frog in a sock when Motley Fool picks up on it and completely flip flops on their opinion and starts shilling which attracts the plebs. Anyhow I have a buy order at 7.1 to fill for another 180,000 shares so.........